Jeffery Sheldon

Is the CEO, General Partner & Managing Director/Founder of CitareTx Investment Partners, a medical device venture capital fund; Managing Director of CitareTx Management LLC, the venture fund management, incubator & operating company; Chairman & CEO/Founder of three CitareTx portfolio companies: EMIT Corporation, Houston Medical Robotics, Inc., and Coagulex, Inc.; and President & CEO of Yguana Entertainment, Inc. Mr. Sheldon also serves as a member of the University of Minnesota Discovery Capital Strategic Advisory Board; member of the University of Texas Medical Branch Health Technology Seed Fund Investment Review Committee; member of the University of Houston Cougar Venture Fund Board of Advisors; member of the Medical Bridges Advisory Counsel; and was a Houston Technology Center Board Director until it merged with Houston Exponential. Mr. Sheldon was also the Founder/Chairman & CEO of IDev Technologies, Inc. sold to Abbott in August 2013 for $310 Million; Founder/Chairman & CEO of Nittany Polymedics, Inc; Director of Technology Development at MD Anderson Cancer Center; founder of the Technology Management Office at The University of Texas Medical Branch; and held various leadership positions at Rockwell International/Rockwell Space Operations Company. Mr. Sheldon holds a B.S. Aerospace Engineering & Mechanics, with distinction, from the University of Minnesota and a M.B.A. from the University of Houston – Clear Lake.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Chrysalis BioTherapeutics

Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure.


Industries

Employees

1-10

Links